FDA-Cleared TMS Devices Compared: Ampa One, NeuroStar, BrainsWay, MagVenture & Magstim
Five major FDA-cleared TMS devices compete with distinct coil types, treatment protocols, and business models. NeuroStar dominates market share but uses costly pay-per-use fees. BrainsWay offers the broadest indication coverage with H-coil technology. MagVenture provides modular research flexibility with liquid cooling. Magstim combines heritage with competitive pricing and included navigation.Ampa One enters as the clinician-designed option built specifically for accelerated TMS protocols, featuring camera-based navigation and dual coil types (L and M) in a compact form factor. No single device wins every category. Your choice depends on practice workflow, target indications, and business model preferences.The comparison table below consolidates key specifications for quick reference.